| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.
|
Aliment Pharmacol Ther
|
2014
|
2.11
|
|
2
|
Brief report: heavy-chain deposition disease.
|
N Engl J Med
|
1993
|
1.63
|
|
3
|
[Association of celiac disease and antiphospholipid syndrome].
|
Presse Med
|
1998
|
1.39
|
|
4
|
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study).
|
Eur J Cancer
|
2013
|
1.36
|
|
5
|
In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts.
|
Int J Cancer
|
1994
|
1.33
|
|
6
|
HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.
|
Cancer Res
|
1997
|
1.22
|
|
7
|
Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes.
|
Clin Exp Immunol
|
2007
|
1.20
|
|
8
|
Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002).
|
Br J Cancer
|
2003
|
1.03
|
|
9
|
Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate.
|
Cell Death Differ
|
1998
|
1.02
|
|
10
|
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].
|
Rev Neurol (Paris)
|
2008
|
1.01
|
|
11
|
Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27.
|
Eur J Biochem
|
1996
|
0.98
|
|
12
|
Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system.
|
J Immunol
|
2001
|
0.97
|
|
13
|
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.
|
Cell Death Differ
|
2010
|
0.95
|
|
14
|
Concurrent lymphoma and metastatic breast carcinoma in the axillary, confounding sentinel lymph-node biopsy.
|
Eur J Surg Oncol
|
2004
|
0.94
|
|
15
|
False aneurysm of the internal carotid artery in Behçet's disease: successful combined endovascular treatment with stent and coils.
|
Rheumatology (Oxford)
|
1999
|
0.93
|
|
16
|
Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo.
|
Cancer Res
|
1986
|
0.93
|
|
17
|
Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.
|
Cancer Res
|
1990
|
0.92
|
|
18
|
Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors.
|
Int J Cancer
|
1999
|
0.89
|
|
19
|
Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells.
|
Int J Cancer
|
1992
|
0.88
|
|
20
|
Circumvention of confluence-dependent resistance in a human multi-drug-resistant colon-cancer cell line.
|
Int J Cancer
|
1995
|
0.87
|
|
21
|
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
|
Cancer Radiother
|
2011
|
0.86
|
|
22
|
[The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats].
|
Chirurgie
|
1999
|
0.86
|
|
23
|
Cytofluorescence localization of adriamycin in resistant colon cancer cells.
|
Cancer Chemother Pharmacol
|
1984
|
0.86
|
|
24
|
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
|
Ann Oncol
|
2011
|
0.85
|
|
25
|
[Cavernous hemangioma of the liver associated with angiosarcoma: malignant transformation?].
|
Gastroenterol Clin Biol
|
1991
|
0.84
|
|
26
|
Cytotoxic effects of acoustic cavitation on HT-29 cells and a rat peritoneal carcinomatosis in vitro.
|
Cancer Res
|
1991
|
0.84
|
|
27
|
Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
|
Eur J Surg Oncol
|
2001
|
0.83
|
|
28
|
New insights into the kinetic resistance to anticancer agents.
|
Cytotechnology
|
1998
|
0.82
|
|
29
|
Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells.
|
Int J Cancer
|
1998
|
0.82
|
|
30
|
[Intratumoral chemotherapy: experimental data and applications to head and neck tumors].
|
Ann Otolaryngol Chir Cervicofac
|
2007
|
0.82
|
|
31
|
Kinetic resistance to anticancer agents.
|
Cytotechnology
|
1993
|
0.82
|
|
32
|
Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.
|
Cancer Res
|
1992
|
0.81
|
|
33
|
Side-effects of high-dose intravenous (pulse) methylprednisolone therapy cured by potassium infusion.
|
Br J Rheumatol
|
1998
|
0.80
|
|
34
|
Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.
|
J Clin Oncol
|
1992
|
0.80
|
|
35
|
Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.
|
Crit Rev Oncol Hematol
|
2009
|
0.80
|
|
36
|
[Intraperitoneal chemo-hyperthermia with "overflow" open abdomen].
|
Ann Chir
|
2001
|
0.79
|
|
37
|
Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth.
|
Cancer Gene Ther
|
2008
|
0.79
|
|
38
|
Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma.
|
Anticancer Drugs
|
2001
|
0.79
|
|
39
|
Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.
|
Br J Rheumatol
|
1998
|
0.79
|
|
40
|
Histoimmunological characterization of the cellular reaction to liver metastases induced by colon cancer cells in syngeneic rats.
|
Invasion Metastasis
|
1989
|
0.78
|
|
41
|
mdr 1 gene-expression and villin synthesis in a colon cancer cell line differentiated by sodium butyrate.
|
Anticancer Res
|
1993
|
0.78
|
|
42
|
[Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
|
Cancer Radiother
|
2008
|
0.78
|
|
43
|
Treatment of experimental liver metastases in the rat by continuous intraportal infusion of 5-fluorouracil and heparin: a pilot study.
|
Anticancer Drugs
|
1990
|
0.78
|
|
44
|
Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells.
|
Cancer Lett
|
1994
|
0.78
|
|
45
|
[Perforation of colonic diverticulum under corticoids: a complication to be known and recognized].
|
Rev Med Interne
|
1995
|
0.78
|
|
46
|
[Hepatocellular carcinoma in a healthy liver possibly due to long-term use of cyproterone acetate].
|
Presse Med
|
2000
|
0.78
|
|
47
|
[Anticancer chemotherapy. Prevention of toxicity].
|
Presse Med
|
1998
|
0.77
|
|
48
|
[Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
|
Gastroenterol Clin Biol
|
2000
|
0.77
|
|
49
|
Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
|
Cancer
|
1991
|
0.77
|
|
50
|
Cinchonine per os: efficient circumvention of P-glycoprotein-mediated multidrug resistance.
|
Anticancer Drug Des
|
1995
|
0.77
|
|
51
|
Combined chemotherapy and radiotherapy for esophageal carcinoma in a hemodialyzed patient. Long-term survival.
|
Nephron
|
1996
|
0.77
|
|
52
|
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.
|
Leukemia
|
2000
|
0.77
|
|
53
|
Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM.
|
Leukemia
|
1994
|
0.77
|
|
54
|
Retroperitoneal fibrosis and infection of an aortic graft prosthesis: diagnosis and therapeutic problems.
|
Clin Cardiol
|
1997
|
0.77
|
|
55
|
New ursolic and betulinic derivatives as potential cytotoxic agents.
|
J Enzyme Inhib Med Chem
|
2003
|
0.77
|
|
56
|
Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.
|
Br J Cancer
|
1994
|
0.77
|
|
57
|
[Evaluation of povidone abdominal washing for prevention of peritoneal cancer cell seeding: experimental study in the rat].
|
Ann Chir
|
2002
|
0.76
|
|
58
|
[Bolus of corticoids: side-effects and precautions of use].
|
Presse Med
|
1997
|
0.76
|
|
59
|
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.
|
Br J Cancer
|
2011
|
0.75
|
|
60
|
Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR.
|
Nouv Rev Fr Hematol
|
1990
|
0.75
|
|
61
|
Aspirin and systemic mastocytosis.
|
Lancet
|
1989
|
0.75
|
|
62
|
[Intratumoral chemotherapy in an experimental animal model: another therapeutic possibility in cancerology].
|
Presse Med
|
1999
|
0.75
|
|
63
|
[Animal models for hepatic metastases].
|
Gastroenterol Clin Biol
|
1991
|
0.75
|
|
64
|
[Auto-immune pathology after placement of a mersilene preperitoneal plate].
|
Ann Med Interne (Paris)
|
1990
|
0.75
|
|
65
|
[Intra-alveolar hemorrhages in systemic diseases].
|
Presse Med
|
1992
|
0.75
|
|
66
|
[Association of infectious aneurysm and microbial spondylodiscitis: physiopathological hypotheses, diagnostic and therapeutic approach].
|
Rev Med Interne
|
1994
|
0.75
|
|
67
|
Liposomal mitoxantrone for the local treatment of peritoneal carcinomatosis induced by colon cancer cells in mice.
|
Anticancer Drug Des
|
1994
|
0.75
|
|
68
|
[Hypocalcemia induced by cisplatin. Inappropriate parathyroid response due to hypomagnesemia].
|
Presse Med
|
1991
|
0.75
|
|
69
|
[Treatment of cancer and hematological malignancy in elderly people: oncogeriatrics as a discipline for the future (Part I): geriatric evaluation and management of solid tumors].
|
Rev Med Interne
|
2004
|
0.75
|
|
70
|
[Early signs of systemic disease in patients taking minocycline chlorhydrate].
|
Presse Med
|
1999
|
0.75
|
|
71
|
P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma.
|
Leukemia
|
1991
|
0.75
|
|
72
|
[The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
|
Presse Med
|
1998
|
0.75
|
|
73
|
[Consumption coagulopathy in a periprosthetic fracture of the hip].
|
Presse Med
|
1996
|
0.75
|
|
74
|
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
|
J Exp Clin Cancer Res
|
2001
|
0.75
|
|
75
|
[Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression].
|
Pathol Biol (Paris)
|
2001
|
0.75
|
|
76
|
[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
|
Presse Med
|
1989
|
0.75
|
|
77
|
[Iatrogenic aseptic meningitis].
|
Presse Med
|
1998
|
0.75
|
|
78
|
Efficacy of colchicine alone or in combination with vinca alkaloids in severe corticoid-resistant thrombocytopenic purpura: six cases.
|
Am J Med
|
1999
|
0.75
|
|
79
|
Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
|
Gastroenterol Clin Biol
|
1991
|
0.75
|
|
80
|
[A case for diagnosis: phlegmasia cerulea dolens].
|
Ann Dermatol Venereol
|
1994
|
0.75
|
|
81
|
[Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
|
Gastroenterol Clin Biol
|
1989
|
0.75
|
|
82
|
[Fight against cancer of the exocrine pancreas: stagnation or progress? The point of view of the Fondation française de cancérologie digestive (FFCD)].
|
Cancer Radiother
|
1997
|
0.75
|
|
83
|
Bidentatoside I, a new triterpene saponin from Achyranthes bidentata.
|
J Nat Prod
|
2001
|
0.75
|
|
84
|
[Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].
|
Ann Chir
|
2000
|
0.75
|
|
85
|
[Dilated cardiomyopathy disclosing dermatopolymyositis. Management].
|
Ann Cardiol Angeiol (Paris)
|
1993
|
0.75
|
|
86
|
[Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles].
|
Ann Biol Clin (Paris)
|
2002
|
0.75
|
|
87
|
Serum concentrations of amiodarone required for an in vivo modulation of anthracycline resistance.
|
Anticancer Res
|
1990
|
0.75
|
|
88
|
A new major triterpene saponin from the roots of Cucurbita foetidissima.
|
J Nat Prod
|
2000
|
0.75
|
|
89
|
[False hyperphosphoremia in multiple myeloma. Interference of monoclonal immunoglobulin G with the determination of blood phosphorus level].
|
Rev Med Interne
|
1992
|
0.75
|
|
90
|
[Concomitant chemoradiotherapy in the therapeutic strategy of adenocarcinoma of the exocrine pancreas and stomach].
|
Cancer Radiother
|
1998
|
0.75
|
|
91
|
Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model.
|
Eur J Surg Oncol
|
2009
|
0.75
|
|
92
|
[Bone metastasis of hepatocellular carcinoma. Apropos of 22 cases].
|
Rev Rhum Ed Fr
|
1993
|
0.75
|